What kind of interaction is it?

Caution: an interaction that may reduce efficacy or raise side-effect risk and warrants monitoring.

Is this interaction backed by published research?

Yes. NutriStack lists 2 citation rows for the Psilocybin + Sertraline pair, each linking to PubMed by PMID where available. Full sourcing methodology at https://nutristackapp.com/methodology/interactions.

Interaction databaseSupplement × PrescriptionReviewed May 2026

Psilocybin and Sertraline, a caution.

Q: Can I take Psilocybin and Sertraline together?

Possibly, but with caution. Psilocybin and Sertraline have a documented caution-tier interaction. Sertraline blocks the serotonin transporter and occupies postsynaptic 5-HT2A receptors over time, blunting psilocybin's intended psychedelic effect. Most psilocybin therapy trials require patients to be off SSRIs for several weeks before dosing. The combined serotonergic load also carries a theoretical risk of serotonin syndrome, though documented cases with classical psychedelics are rare.

Q: How does this affect a NutriStack Stack Score?

-5 to your Stack Score per scored caution row.

Sertraline blocks the serotonin transporter and occupies postsynaptic 5-HT2A receptors over time, blunting psilocybin's intended psychedelic effect. Most psilocybin therapy trials require patients to be off SSRIs for several weeks before dosing. The combined serotonergic load also carries a theoretical risk of serotonin syndrome, though documented cases with classical psychedelics are rare.

2 primary source citations. Emerging evidence. Last verified May 30, 2026.

Open the interaction checker →Read the methodology

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances: Psilocybin and Sertraline
Pair type: Caution
Evidence (highest tier): Emerging
Source citations: 2 sources
Stack Score effect: −5 to your Stack Score (per scored caution row).
Scope: Supplement × Prescription
Last verified: May 30, 2026

Caution · Emerging evidence

Caution

What is happening. Sertraline blocks the serotonin transporter and occupies postsynaptic 5-HT2A receptors over time, blunting psilocybin's intended psychedelic effect. Most psilocybin therapy trials require patients to be off SSRIs for several weeks before dosing. The combined serotonergic load also carries a theoretical risk of serotonin syndrome, though documented cases with classical psychedelics are rare.

Mechanism. Chronic SSRI exposure downregulates and desensitizes 5-HT2A receptors and elevates baseline synaptic serotonin, both of which attenuate psilocin's 5-HT2A agonism. Some additive serotonergic activity also raises theoretical risk of serotonin syndrome.

Recommendation. Do not take psilocybin while on sertraline if you want a meaningful experience — the response will likely be blunted. If you have stopped sertraline, follow clinical-trial protocols and wait at least 2 weeks before psilocybin.

Sources (2)

Stack Score

How this pair moves the number.

Effect on the composite score

If both Psilocybin and Sertraline are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

Open the interaction checker →Browse the full research index